News
Current position:Product Center > Cell lines > Immune checkpoints > PD1-PDL1 > Mouse_PD-1 Reporter Jurkat Cell Line
Mouse_PD-1 Reporter Jurkat Cell Line
Description
Cat. No: GM-C25661
Product: Mouse_PD-1 Reporter Jurkat Cell Line


PD-1 is an immunosuppressive receptor on activated T and B cells, essential for regulating immune responses to tumor antibodies and self-antigens. Its interaction with ligands PD-L1 or PD-L2 inhibits TCR signaling, affecting cell proliferation, transcriptional activation, and cytokine production. Therapeutic antibodies and Fc fusion proteins blocking this interaction have shown promise in cancer clinical trials.

Mouse_PD-1 Reporter Jurkat Cell Line is a stable clonal Jurkat cell line constructed using lentiviral technology, constitutive expression of the mouse PD-1 gene, along with signal-dependent expression of a luciferase reporter gene. The Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) is another stable clonal cell line that expresses mouse PD-L1 and a cell surface protein that activates homologous TCR in an antigen-independent manner. Co-culturing these cells inhibits TCR signaling and luciferase expression due to the PD-1/PD-L1 interaction. Adding antibodies that block this interaction relieves the inhibition, allowing TCR signaling and luciferase expression to resume. This setup can assess the efficacy and stability of antibodies and biologics that block the PD-1/PD-L1 interaction.
Data
Response to Anti-H_CD274(PDL1) hIgG1 Antibody (Atezolizumab). Serial dilutions of the Anti-H_CD274(PDL1) hIgG1 Antibody (Atezolizumab) (Cat. GM-31740AB) was incubated with 2E4 cells/well of the Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) in a 96-well plate for 1 hour. Subsequently, Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) with a concentration of 1E5 cells/well was added, and the co-culture proceeded for an additional 6 hours in assay buffer (RPMI 1640 + 1% FBS + 1% P.S). Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Genomeditech/GM-040503). The results indicated a maximum blocking fold of approximately [7.1]. Data are shown by drug mass concentration.
Response to Anti-Mouse_PD1 mIgG1 Antibody. Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) was seeded at a density of 1E4 cells per well in a 96-well plate and incubated overnight. The next day, serial dilutions of the Anti-Mouse_PD1 mIgG1 Antibody (Cat. GM-28206AB) were incubated with 1E5 cells/well of the Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) in a 96-well plate for 1 hour, and then added to the pre-seeded cells. The mixture was incubated for an additional 6 hours. Firefly luciferase activity is then measured using the ONE-Glo™ Luciferase Assay System (Promega/E6120). The results indicated a maximum blocking fold of approximately [6.9]. Data are shown by drug mass concentration.
Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) was determined by flow cytometry using Anti-Mouse_PD1 mIgG1 Antibody (Cat. GM-28206AB).
Specifications
Cat. NoGM-C25661
ProductMouse_PD-1 Reporter Jurkat Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+3.5 μg/mL Blasticidin+0.75 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
PuromycinGenomeditech/GM-040401
Mouse PDL1 aAPC CHO-K1 Cell LineGenomeditech/GM-C25791
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)Genomeditech/GM-31740AB
Anti-mouse_PD1 mIgG1 Antibody(RMP1-14)Genomeditech/GM-28206AB
ONE-Glo™ Luciferase Assay SystemPromega/E6120
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1 - 2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3.5 μg/mL Blasticidin+0.75 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1.5 - 2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current Position:Product Center > Cell lines > Immune checkpoints > PD1-PDL1 > Mouse_PD-1 Reporter Jurkat Cell Line
classify
Mouse_PD-1 Reporter Jurkat Cell Line
Description
Cat. No: GM-C25661
Product: Mouse_PD-1 Reporter Jurkat Cell Line


PD-1 is an immunosuppressive receptor on activated T and B cells, essential for regulating immune responses to tumor antibodies and self-antigens. Its interaction with ligands PD-L1 or PD-L2 inhibits TCR signaling, affecting cell proliferation, transcriptional activation, and cytokine production. Therapeutic antibodies and Fc fusion proteins blocking this interaction have shown promise in cancer clinical trials.

Mouse_PD-1 Reporter Jurkat Cell Line is a stable clonal Jurkat cell line constructed using lentiviral technology, constitutive expression of the mouse PD-1 gene, along with signal-dependent expression of a luciferase reporter gene. The Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) is another stable clonal cell line that expresses mouse PD-L1 and a cell surface protein that activates homologous TCR in an antigen-independent manner. Co-culturing these cells inhibits TCR signaling and luciferase expression due to the PD-1/PD-L1 interaction. Adding antibodies that block this interaction relieves the inhibition, allowing TCR signaling and luciferase expression to resume. This setup can assess the efficacy and stability of antibodies and biologics that block the PD-1/PD-L1 interaction.
Data
Response to Anti-H_CD274(PDL1) hIgG1 Antibody (Atezolizumab). Serial dilutions of the Anti-H_CD274(PDL1) hIgG1 Antibody (Atezolizumab) (Cat. GM-31740AB) was incubated with 2E4 cells/well of the Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) in a 96-well plate for 1 hour. Subsequently, Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) with a concentration of 1E5 cells/well was added, and the co-culture proceeded for an additional 6 hours in assay buffer (RPMI 1640 + 1% FBS + 1% P.S). Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Genomeditech/GM-040503). The results indicated a maximum blocking fold of approximately [7.1]. Data are shown by drug mass concentration.
Response to Anti-Mouse_PD1 mIgG1 Antibody. Mouse PDL1 aAPC CHO-K1 Cell Line (Cat. GM-C25791) was seeded at a density of 1E4 cells per well in a 96-well plate and incubated overnight. The next day, serial dilutions of the Anti-Mouse_PD1 mIgG1 Antibody (Cat. GM-28206AB) were incubated with 1E5 cells/well of the Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) in a 96-well plate for 1 hour, and then added to the pre-seeded cells. The mixture was incubated for an additional 6 hours. Firefly luciferase activity is then measured using the ONE-Glo™ Luciferase Assay System (Promega/E6120). The results indicated a maximum blocking fold of approximately [6.9]. Data are shown by drug mass concentration.
Mouse_PD-1 Reporter Jurkat Cell Line (Cat. GM-C25661) was determined by flow cytometry using Anti-Mouse_PD1 mIgG1 Antibody (Cat. GM-28206AB).
Specifications
Cat. NoGM-C25661
ProductMouse_PD-1 Reporter Jurkat Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+3.5 μg/mL Blasticidin+0.75 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
PuromycinGenomeditech/GM-040401
Mouse PDL1 aAPC CHO-K1 Cell LineGenomeditech/GM-C25791
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)Genomeditech/GM-31740AB
Anti-mouse_PD1 mIgG1 Antibody(RMP1-14)Genomeditech/GM-28206AB
ONE-Glo™ Luciferase Assay SystemPromega/E6120
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1 - 2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3.5 μg/mL Blasticidin+0.75 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1.5 - 2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit